29th
Annual International Conference of the IEEE Engineering in Medicine
and Biology Society
in conjunction with
the biennial Conference of the French Society of Biological and
Medical Engineering (SFGBM)
August 23-26,
2007
Convention Center, “Cité
Internationale”, Lyon, France
***
Keynote Speaker Information
***
Keynote speakers' abstracts and short biographies
can be viewed here.
***
Car Parking Available
at Convention Center***
Car Parking facilities will be available
at the Convention Center for conference delegates.
If you wish to avail of this service, it
is important to note that you should park your vehicle in
section P2
of the car park.
***
Special Tours Available
***
A series of social activities and visits
have been organized by Easylife. In conjunction
with the History Committee, tours to the medicine and science
museums have been arranged. Also available, are visits to
the Beaujolis Vineyard and the "Chocolate Atelier"
at Bernachon.
(Please
note: No further changes to the program are possible)
We wish to thank the following
for their contribution to the success of this conference:
European Office of Aerospace Research and Development,
Air Force Office of Scientific Research, United States
Air Force Research Laboratory.
Please note: Corresponding
authors are required to complete
registration payment prior to uploading their final papers.
Attention
Authors
To request your formal acceptance letter, login
to the PaperCept database
using your PIN and password.
There is an option in your workspace to
request an acceptance letter. Be sure to select your paper and
then click
the link.
Presenter Guidelines are now available
to download from here.
Poster Presenters will be able to get their poster
printed prioir to the conference and will be erected prior to
your session. More information on the service can be downloaded
from here, and the
order form can be downloaded from here.
Keynote
Speakers
Microscale bioengineering
inspired by nature: from widgets to cell biology
Sponsored by Philips Research
David J. Beebe
Abstract
Nature has accomplished impressive functionality through evolution
that far surpasses our ability to recreate similar functionality
through engineered systems. While nature is limited to leveraging
and adapting the physics of the natural world, engineers are free
to imagine. With notable exceptions such as digital computing, the
freedom to imagine has often led to “over engineered”
solutions rather than the simple solutions nature often achieves.
At the micro scale the dominate physical phenomena is often different
than at the macro scale. For example, diffusive transport becomes
increasingly important and surface tension can dominate over gravitational
forces. The scaling of these natural phenomena lead to a very different
physical world than the one we live in and presents opportunities
for elegant harnessing of these forces in useful and interesting
ways. Microscale forces can be leveraged to realize a variety of
functions ranging from sensing and control to manipulation and processing
to creating systems aimed at recapitulating in vivo cellular structure
and function. The presentation will include a microscale tutorial,
examples of bioinspired micro/cellular scale engineering and a discussion
of the promise and challenges in mimicking cellular microenvironments
in vivo.
Brief Biography
David J. Beebe is a Professor in the Department
of Biomedical Engineering at the University of Wisconsin-Madison.
He is also a member of the UW Comprehensive Cancer Center, Stem
Cell Program, Materials Science Program, Biotechnology Training
Program, and Genomic and Sciences Training Program. From 1996 to
1999, he was an Assistant Professor at the University of Illinois
at Urbana- Champaign. From 1994 to 1996, David was an Assistant
Professor at Louisiana Tech University. He received the B.S. (1987),
M.S. (1990) and Ph.D. (1994) in Electrical Engineering from the
University of Wisconsin-Madison. He is the recipient of the IEEE
EMBS Early Career Achievement Award, the Romnes Award at UW-Madison
and Lab on a Chip, Royal Society of Chemistry and Corning, Pioneers
of Miniaturization Prize. He has also served as an Associate Editor
for Journal of MicroeElectroMechanical Systems, the Journal of Biomechanical
Engineering and is currently on the editorial board of Lab on a
Chip.
He has published over 100 peer
reviewed articles in leading journals including Science, Nature
and the Proceedings of the National Academy of Sciences. Prof. Beebe
is a co-founder of Vitae LLC, Salus LLC and Ratio Inc. Past research
topics have included development of non-traditional autonomous micro
fluidic devices and systems, and the study of cell and embryo development
in microenvironments. David’s current interests center around
understanding the role stem/progenitor cells play in the development
of the mammary gland. David is currently in the midst of a retraining
effort in cancer biology via a 5 year NIH K25 award.
What is the added value of
Biomedical Engineering technologies?
Sponsored by ACIES
Jean-Claude Healy
Abstract
All the Nations are convinced the Research and Development (RD)
in general and in the Biomedical Engineering (BME) area in particular,
will save the present growing problems of the planet and accordingly,
try to convince the tax payers to invest money and human resources
for a better future quality of life. Of course this assumption is
valid but, learnt from the last 3 century history of BME, must be
documented. The first naïve approach is to be convinced a magic
unknown new technology will solve tomorrow the present global health
and medical problems. The second approach highlights the economical
impact including employment in the relevant industry. Many others
approaches focuses on the progress of knowledge and sciences, on
the global competition and others competitive advantages. But two
main lessons are learnt from the past:
The first lesson is: the impact of technologies are peanuts
without an ad hoc implementation systems, or, in others words,
the long term impacts of new technologies are not related to
the direct today performance of the techniques, but to the long
term ability of the technique to induce the reengineering of
the overall system. At the end of the XIX century, the drugs
redesigned completely the treatment procedures, during the XX
century the medical imaging solutions redesigned the diagnostic
procedures and now the information and communication technologies
are fostering a complete revision of the traditional of the
various healthcare delivery systems. The reengineering of the
system is the final goal of the techniques and the technical
solutions are not a treatment for curing the present diseases
of healthcare system. But towards which system? A technical
or economical driven systems? No
The second lesson is: The present “patient and disease
centered Healthcare delivery systems” are the common paradigms
for reasoning and are based on the assumption “sciences
will save me”. Due to different reasons (economy, acceptance,
accessibility, sustainability etc) this paradigm is outdated
and a new one, more “citizen and Health centered paradigm”
must be urgently designed. This new paradigm suppose a continuous
personal long life commitment and is now largely facilitated
by the progress of the personal predictive medicine and communication
technologies. In addition this paradigm is not limited to the
rich countries (25% of population) but equally valid for low
income countries and 100% of the population of the world.
These lessons induce substantial operational consequences:
the power and the efficiency of RD are not just limited to the performance
of the new products, so good they are, but to the capability to
induce changes in the overall system towards an acceptable one.
On the reverse, with the technologies of the moment , substantial
productivity gains and better results can be expected from RD focused
not on technics but on the systems themselves. As a whole, the medical
system is extremely conservative and in average ,17 years, ( half
generation…), are needed for a full approval of qualified
techniques. Each component of the value chain is concerned: HC professionals,
final users, decision makers, financial authorities, politicians,
etc. This is unacceptable.
The Biomedical Engineers have the intellectual capability to develop
the due systemic approaches of the problems and to propose solutions,
but the fragmentation of the research and disciplines, the competition,
and the lack of top level responsibility don’t facilitate
robust sustainable implementation plans. Accordingly, in addition
to RD activities, we need new vision, new long term vision, new
global vision, new integrated vision for boosting the new “citizen
centered Health delivery systems”. Here is the value of the
technic.
Brief Biography
Prof Jean-Claude Healy, PhD MD (Paris University),
was for 30 years Professor of Biophysics and Medical informatics
in a range of leading French Universities and Hospitals. He joined
the EU DG INFSO in 1995 as Head of Unit "Telematics Applications
for Health" (1995-2004), “IST Applications relating to
Health”, eHealth. He is presently Senior Advisor to the UN
GAID (Global Alliance for ICT and Development) in New York and has
been recently appointed by the French Minister of health as a Member
of the High Level Public Health Council.
He has published more than 250
scientific publications and additional administrative documents
for the eHealth Resolution (WHA 58 28) , WHO eHealth action Plan,
the EU-WHO eHealth report for the World Summit on Information Society
etc.
EMBS
Information
4th IEEE-EMBS International Summer School
and Symposium on Medical Devices and Biosensors (ISSS-MDBS
2007)
